The world's oceans are losing oxygen—and rapidly. The principal cause is the increasing warming of the oceans, which reduces the solubility of oxygen in water and increases respiratory activity. In ...
Data from two trials presented at the recent SGO meeting, have practice-changing implications for ovarian cancer treatment, according to Dr Bradley R. Corr. The NRG-GY019 trial established carboplatin ...
Judging by my inbox, there’s a misapprehension about how to deal with Iran among many supporters of the “finish the job” line of thinking. They contend that the choice between continuing or ending the ...
Please provide your email address to receive an email when new articles are posted on . MUNICH — A large observational study involving hundreds of thousands of patients in the United States saw no ...
ANN ARBOR, Mich. -- With a new coaching staff, there are bound to be changes to the Michigan football program. And one of the big ones this spring appears to be how the team practices. The Wolverines ...
After months of feeling off, down, and exhausted, I got a call from my doctor. At just 45 years old, I'd entered postmenopause. I had none of the common physical symptoms (other than the occasional ...
Practicing law is a privilege, and while the work will always be demanding, it should still feel like a path you chose—not a cage you can’t leave. In the practice of law, long hours, high expectations ...
Want more tried and tested recommendations from the Editors of Women’s Health? Sign up to our monthly newsletter The Edit. Click here to subscribe. We can all agree kids should be outside more. And ...
CLEVELAND — A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman Cancer Center in Cleveland has identified the first validated ...
2026 National Proton Conference to Spotlight Practice-Changing Data, Expanding Access to Cancer Care
JACKSONVILLE, Fla., March 3, 2026 /PRNewswire/ -- The National Association for Proton Therapy (NAPT), the nation's leading organization dedicated to increasing patient access to advanced cancer ...
Reorganizations challenge even the most stable company cultures. What separates establishments that withstand change from those unable to avoid fracture under pressure? In large part, it’s the way HR ...
Perioperative enfortumab vedotin plus pembrolizumab in KEYNOTE-B15/EV-304 met event-free and overall survival end points versus gemcitabine-cisplatin, with tolerability and post-cystectomy feasibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results